RLT Channel Series
Enhancing Understanding of Radioligand Therapy (RLT) for People Living with Cancer
The goal of this new format is to demystify radioligand therapy (RLT) by providing clear and practical information. It aims to help individuals living with cancer, as well as their loved ones, understand how the therapy works, its potential benefits, and how it can be integrated into the care pathway.
The RLT Channel Series is evolving into one of our key initiatives, offering a recurring platform to spotlight various cancers and explore their treatment possibilities through Radiotheranostics. Each program is designed to provide comprehensive insights, from addressing global challenges to highlighting local perspectives and advancements.
Introduction of the series:
Episode 1: Prostate Cancer’s New Hope: RLT in Action
The first episode is designed for individuals living with prostate cancer, their loved ones, and anyone interested in learning more about this treatment option.
Let’s take a closer look at a subject that touches the lives of many men: prostate cancer.
Episode 1: Prostate Cancer’s New Hope: RLT in Action – Global focus
Episode 1: Nouvel espoir pour le cancer de la prostate : La RLT en Action – Focus Belgique
Speakers
Mrs. Rebecca Lo bue
CEO of the Oncidium foundation
Prof. Zéna Wimana, PhD
Director of Radiopharmacy at University Hospital of Brussels (H.U.B.) – Jules Bordet Institute.
Dr. Erik Briers, MS PhD
Vice Chairman of Europa Uomo & Vice Chairman of Wij Ook vzw
Prof. Dr. Nadia Withofs, MD PhD
Nuclear medicine Physician at CHU Liege
Dr. Vincent Vanhaudenarde, MD
Medical Oncologist at CHU UCL Namur